Misclassification can explain most apparent regression of age-related macular degeneration: Results from multistate models with misclassification

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 3, 2014, Pages 1780-1786

  Gangnon, Ronald E ^a   Lee, Kristine E ^a   Klein, Barbara E K ^a   Iyengar, Sudha K ^b   Sivakumaran, Theru A ^b,c   Klein, Ronald ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Age related macular degeneration; CFH; Epidemiology

Indexed keywords

ADULT; AGE; AGED; ALLELE; ARTICLE; COMPLEMENT FACTOR H GENE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DNA POLYMORPHISM; EYE PHOTOGRAPHY; FEMALE; FOLLOW UP; GENDER; GENE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REMISSION; RETINA MACULA AGE RELATED DEGENERATION; SURVIVAL TIME;

AGE-RELATED MACULAR DEGENERATION; CFH; EPIDEMIOLOGY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COMPLEMENT FACTOR H; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; INCIDENCE; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; WISCONSIN;

EID: 84897832946     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12375     Document Type: Article

References (48)

1. Gass JD. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol. 1973;90:206-217.
2. Bressler NM, Munoz B, Maguire MG, et al. Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities: Waterman study. Arch Ophthalmol. 1995;113: 301-308.
3. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997;104:7-21.
4. Klaver CC, Assink JJ, van Leeuwen R, et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci. 2001;42:2237-2241.
5. Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 2002;109:1767-1779.
6. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam Study. Arch Ophthalmol. 2003;121:519-526.
7. Mitchell P, Wang JJ, Foran S, Smith W. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology. 2002;109:1092-1097.
8. Wang JJ, Foran S, Smith W, Mitchell P. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch Ophthalmol. 2003;121:658-663.
9. Sparrow JM, Dickinson AJ, Duke AM, Thompson JR, Gibson JM, Rosenthal AR. Seven year follow-up of age-related maculopathy in an elderly British population. Eye (Lond). 1997;11:315-324.
10. Buch H, Nielsen NV, Vinding T, Jensen GB, Prause JU, la Cour M. 14-year incidence, progression, and visual morbidity of agerelated maculopathy: the Copenhagen City Eye Study. Ophthalmology. 2005;112:787-798.
11. Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Gangnon RE. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology. 2007;114:253-262.
12. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385-389.
13. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419-421.
14. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and agerelated macular degeneration. Science. 2005;308:421-424.
15. Rivera A, Fisher SA, Fritsche LG, et al. Hypothetical LOC387715 is a second major susceptibility gene for agerelated macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet. 2005; 14:3227-3236.
16. Seddon JM, Francis PJ, George S, Schultz DW, Rosner B, Klein ML. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA. 2007; 297:1793-1800.
17. Seddon JM, Reynolds R, Maller J, Fagerness JA, Daly MJ, Rosner B. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci. 2009;50:2044-2053.
18. Klein ML, Francis PJ, Ferris FL III, Hamon SC, Clemons TE. Risk assessment model for development of advanced age-related macular degeneration. Arch Ophthalmol. 2011;129:1543-1550.
19. Seddon JM, Reynolds R, Yu Y, Daly MJ, Rosner B. Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. Ophthalmology. 2011;118:2203-2211.
20. Andersen PK, Keiding N. Multi-state models for event history analysis. Stat Methods Med Res. 2002;11:91-115.
21. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. 2nd ed. New York, NY: John Wiley & Sons; 2002.
22. Lawless JF. Statistical Models and Methods for Lifetime Data. 2nd ed. New York, NY: John Wiley & Sons; 2002.
23. Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York, NY: Springer; 2000.
24. Andersen PK, Borgan O, Gill RD, Kieding N. Statistical Models Based on Counting Processes. 1st ed. New York, NY: Springer; 1993.
25. Commenges D. Inference for multi-state models from intervalcensored data. Stat Methods Med Res. 2002;11:167-182.
26. Gentleman RC, Lawless JF, Lindsey JC, Yan P. Multi-state Markov models for analysing incomplete disease history data with illustrations for HIV disease. Stat Med. 1994;13:805-821.
27. Marshall G, Jones RH. Multi-state models and diabetic retinopathy. Stat Med. 1995;14:1975-1983.
28. Gruger J, Kay R, Schumacher M. The validity of inferences based on incomplete observations in disease state models. Biometrics. 1991;47:595-605.
29. Linton KL, Klein BE, Klein R. The validity of self-reported and surrogate-reported cataract and age-related macular degeneration in the Beaver Dam Eye Study. Am J Epidemiol. 1991;134: 1438-1446.
30. Klein R, Klein BE, Linton KL, De Mets DL. The Beaver Dam Eye Study: visual acuity. Ophthalmology. 1991;98:1310-1315.
31. Klein R, Klein BE, Lee KE. Changes in visual acuity in a population: the Beaver Dam Eye Study. Ophthalmology. 1996; 103:1169-1178.
32. Klein R, Klein BE, Lee KE, Cruickshanks KJ, Chappell RJ. Changes in visual acuity in a population over a 10-year period: the Beaver Dam Eye Study. Ophthalmology. 2001;108:1757-1766.
33. Klein R, Klein BE, Lee KE, Cruickshanks KJ, Gangnon RE. Changes in visual acuity in a population over a 15-year period: the Beaver Dam Eye Study. Am J Ophthalmol. 2006;142:539-549.
34. Klein R, Lee KE, Gangnon RE, Klein BE. Incidence of visual impairment over a 20-year period: the Beaver Dam Eye Study. Ophthalmology. In press.
35. Klein R, Klein BE. The Beaver Dam Eye Study: Manual of Operations (Revised). Springfield, VA: US Department of Commerce; 1991;74-112. NTIS Accession No. PB91-149823.
36. Klein R, Klein BE. The Beaver Dam Eye Study II: Manual of Operations. Springfield, VA: US Department of Commerce; 1995;61-90. NTIS Accession No. PB95-273827.
37. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991;98:1128-1134.
38. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin Age-Related Maculopathy Grading System. Springfield, VA: US Department of Commerce; 1991. NTIS Accession No. PB91-184267.
39. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992;99:933-943.
40. Klein R, Myers CE, Meuer SM, et al. Risk alleles in CFH and ARMS2 and the long term natural history of age-related macular degeneration: the Beaver Dam Eye Study. JAMA Ophthalmol. 2013. In press. doi:10.1001/jamaophthalmol. 2013.713.
41. Gangnon RE, Lee KE, Klein BE, Iyengar SK, Sivakumaran TA, Klein R. Effect of the Y402H variant in the complement factor H gene on the incidence and progression of age-related macular degeneration: results from multistate models applied to the Beaver Dam Eye Study. Arch Ophthalmol. 2012;130: 1169-1176.
42. Hui SL, Walter SD. Estimating the error rates of diagnostic tests. Biometrics. 1980;36:167-171.
43. Jackson CH, Sharples LD, Thompson SG, Duffy SW, Couto E. Multistate Markov models for disease progression with classification error. J R Stat Soc Ser D Stat. 2003;52:193-209.
44. Lo SH. Estimation of distribution functions under order restrictions. Stat Decis. 1987;5:251-262.
45. Gangnon RE, King WN. Minimum distance estimation of the distribution functions of stochastically ordered random variables. J R Stat Soc Ser C Appl Stat. 2013;51:485-492.
46. Akaike H. A new look at the statistical model identification. IEEE Trans Automatic Control. 1974;19:716-723.
47. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2009.
48. Jackson CH. Multi-state models for panel data: the msm package for R. J Stat Softw. 2011;38:1-28.